FDA — authorised 28 October 1982
- Application: BLA018781
- Marketing authorisation holder: LILLY
- Local brand name: HUMULIN N
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Switching to NPH insulin in United States
FDA authorised Switching to NPH insulin on 28 October 1982
Marketing authorisations
FDA — authorised 1 July 1991
- Application: BLA019959
- Marketing authorisation holder: NOVO NORDISK INC
- Local brand name: NOVOLIN N
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Diabetes approved in United States
Frequently asked questions
Is Switching to NPH insulin approved in United States?
Yes. FDA authorised it on 28 October 1982; FDA authorised it on 1 July 1991.
Who is the marketing authorisation holder for Switching to NPH insulin in United States?
LILLY holds the US marketing authorisation.